Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

269 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Systematic ultrasound-guided saturation and template biopsy of the prostate: indications and advantages of extended sampling.
Isbarn H, Briganti A, De Visschere PJ, Fütterer JJ, Ghadjar P, Giannarini G, Ost P, Ploussard G, Sooriakumaran P, Surcel CI, van Oort IM, Yossepowitch O, van den Bergh RC; Prostate Cancer Working Group of the European Association of Urology Young Academic Urologists. Isbarn H, et al. Among authors: giannarini g. Arch Esp Urol. 2015 Apr;68(3):296-306. Arch Esp Urol. 2015. PMID: 25948801 Review.
Re: Stephen H. Culp, Paul F. Schellhammer, Michael B. Williams. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study. Eur Urol 2014;65:1058-66.
Ost P, Briganti A, Giannarini G; Prostate Cancer Working Group of the Young Academic Urologist Working Party of the European Association of Urology. Ost P, et al. Among authors: giannarini g. Eur Urol. 2014 Jun;65(6):e97-8. doi: 10.1016/j.eururo.2013.12.009. Epub 2013 Dec 17. Eur Urol. 2014. PMID: 24365126 No abstract available.
Multimodal treatment for high-risk prostate cancer with high-dose intensity-modulated radiation therapy preceded or not by radical prostatectomy, concurrent intensified-dose docetaxel and long-term androgen deprivation therapy: results of a prospective phase II trial.
Guttilla A, Bortolus R, Giannarini G, Ghadjar P, Zattoni F, Gnech M, Palumbo V, Valent F, Garbeglio A, Zattoni F. Guttilla A, et al. Among authors: giannarini g. Radiat Oncol. 2014 Jan 14;9:24. doi: 10.1186/1748-717X-9-24. Radiat Oncol. 2014. PMID: 24423462 Free PMC article. Clinical Trial.
Re: Prasanna Sooriakumaran, Abhishek Srivastava, Shahrokh F. Shariat, et al. A multinational, multi-institutional study comparing positive surgical margin rates among 22,393 open, laparoscopic, and robot-assisted radical prostatectomy patients. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.11.018.
Giannarini G, Suardi N, Briganti A. Giannarini G, et al. Eur Urol. 2014 Jun;65(6):e89-90. doi: 10.1016/j.eururo.2014.01.004. Epub 2014 Jan 15. Eur Urol. 2014. PMID: 24447574 No abstract available.
Preferences in the management of high-risk prostate cancer among urologists in Europe: results of a web-based survey.
Surcel CI, Sooriakumaran P, Briganti A, De Visschere PJ, Fütterer JJ, Ghadjar P, Isbarn H, Ost P, Ploussard G, van den Bergh RC, van Oort IM, Yossepowitch O, Sedelaar JP, Giannarini G; Members of Prostate Cancer Working Group of Young Academic Urologists Working Party; Members of Young Urologists Office of European Association of Urology. Surcel CI, et al. Among authors: giannarini g. BJU Int. 2015 Apr;115(4):571-9. doi: 10.1111/bju.12796. Epub 2014 Aug 11. BJU Int. 2015. PMID: 24802335
269 results